Dementia expert's warning over early sign of Alzheimer's that isn't memory loss

South Africa News News

Dementia expert's warning over early sign of Alzheimer's that isn't memory loss
South Africa Latest News,South Africa Headlines
  • 📰 Daily_Record
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 89%

Research suggests that vision problems may be one of the “first” signs of dementia.

Dementia experts have shared one early Alzheimer's sign to look out for and it's not what you'd expect.

Their visuospatial skills also deteriorate, meaning that they are unable to judge distances correctly. One early sign of the disease could be something as subtle as tripping up the stairs. Dr Jørn Slot Jørgensen, of Laser Eye Clinic London, said that the symptoms may be "subtle" and not immediately noticed, however.

Dr Jørgensen told Express.co.uk : "Some people think that visiting an ophthalmologist is only necessary if you have an eye condition or need vision correction. However, this is a widespread misconception that also applies to medical situations in general.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Daily_Record /  🏆 9. in UK

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Alarm as FDA fast-tracks first antipsychotic drug for agitation in dementiaAlarm as FDA fast-tracks first antipsychotic drug for agitation in dementiaIn trials, the antipsychotic drug brexpiprazole (Rexulti) failed to provide a clinically meaningful benefit and increased the risk of death. Yet the US Food and Drug Administration (FDA) has fast tracked its approval, making Rexulti the first antipsychotic for treating agitation in elderly patients with dementia.
Read more »

FDA approved Rexulti to be the first antipsychotic for treating agitation in elderly patients with dementiaFDA approved Rexulti to be the first antipsychotic for treating agitation in elderly patients with dementiaIn trials, the antipsychotic drug brexpiprazole (Rexulti) failed to provide a clinically meaningful benefit and increased the risk of death. Yet the US Food and Drug Administration (FDA) has fast tracked its approval, making Rexulti the first antipsychotic for treating agitation in elderly patients with dementia.
Read more »

Early signs of dementia can appear in eyes before memory problemsEarly signs of dementia can appear in eyes before memory problemsA study has found that certain changes in the eyes could be one of the first signs of the cruel illness
Read more »

Early signs of dementia can appear in eyes before memory problemsEarly signs of dementia can appear in eyes before memory problemsA new study's findings have been released
Read more »



Render Time: 2025-03-10 06:05:22